Quarterly report pursuant to Section 13 or 15(d)

Revenue Disclosures - Rollforward of Contract Liabilities (Details)

v3.24.3
Revenue Disclosures - Rollforward of Contract Liabilities (Details) - USD ($)
 9 Months Ended
Sep. 30, 2024
Dec. 31, 2022
Company clinics    
Disaggregation of Revenue [Line Items]    
Deferred Revenue $ 3,183,396 $ 7,471,549
Deferred Revenue    
Beginning balance 4,463,747  
Revenue recognized that was included in the contract liability at the beginning of the year (4,173,367)  
Net increase during the period 2,893,016  
Ending balance 3,183,396  
Franchise fees    
Disaggregation of Revenue [Line Items]    
Deferred Revenue 15,216,185 $ 16,629,735
Deferred Revenue    
Beginning balance 16,113,879  
Revenue recognized that was included in the contract liability at the beginning of the year (1,997,255)  
Net increase during the period 1,099,561  
Ending balance $ 15,216,185